Tudor Investment Corp’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-27,525
Closed -$858K 2080
2024
Q3
$858K Buy
+27,525
New +$858K ﹤0.01% 1060
2023
Q3
Sell
-27,769
Closed -$835K 1924
2023
Q2
$835K Sell
27,769
-16,137
-37% -$485K 0.01% 965
2023
Q1
$1.59M Sell
43,906
-36,801
-46% -$1.33M 0.02% 720
2022
Q4
$2.88M Sell
80,707
-11,050
-12% -$394K 0.06% 403
2022
Q3
$3.11M Sell
91,757
-19,426
-17% -$658K 0.07% 360
2022
Q2
$3.22M Sell
111,183
-16,894
-13% -$489K 0.08% 289
2022
Q1
$4.14M Buy
128,077
+41,964
+49% +$1.36M 0.1% 258
2021
Q4
$2.51M Buy
86,113
+17,516
+26% +$511K 0.04% 499
2021
Q3
$1.83M Buy
68,597
+57,797
+535% +$1.54M 0.03% 622
2021
Q2
$333K Sell
10,800
-34,329
-76% -$1.06M 0.01% 1238
2021
Q1
$1.18M Buy
+45,129
New +$1.18M 0.02% 749
2020
Q2
Sell
-29,620
Closed -$533K 1397
2020
Q1
$533K Sell
29,620
-13,627
-32% -$245K 0.05% 467
2019
Q4
$1.03M Buy
43,247
+7,952
+23% +$189K 0.05% 481
2019
Q3
$970K Sell
35,295
-10,970
-24% -$301K 0.03% 499
2019
Q2
$1.53M Buy
46,265
+4,784
+12% +$158K 0.04% 406
2019
Q1
$1.45M Buy
41,481
+5,764
+16% +$202K 0.06% 342
2018
Q4
$1.19M Buy
+35,717
New +$1.19M 0.02% 327
2017
Q2
Sell
-10,548
Closed -$330K 1346
2017
Q1
$330K Sell
10,548
-17,029
-62% -$533K 0.01% 943
2016
Q4
$696K Buy
27,577
+12,777
+86% +$322K 0.02% 522
2016
Q3
$366K Buy
14,800
+300
+2% +$7.42K 0.01% 885
2016
Q2
$295K Sell
14,500
-5,800
-29% -$118K 0.01% 1018
2016
Q1
$310K Sell
20,300
-26,700
-57% -$408K 0.01% 1054
2015
Q4
$632K Buy
47,000
+13,400
+40% +$180K 0.02% 598
2015
Q3
$471K Buy
33,600
+8,700
+35% +$122K 0.02% 749
2015
Q2
$423K Sell
24,900
-18,087
-42% -$307K 0.01% 840
2015
Q1
$520K Buy
42,987
+29,021
+208% +$351K 0.02% 697
2014
Q4
$116K Buy
+13,966
New +$116K ﹤0.01% 1341